問卷

TPIDB > Study Site

Study Site



China Medical University Hospital

  • 2,076

    Total Beds

  • 884

    Total Doctors

  • ctcadm.cmuh@gmail.com
  • Clinical Trial Center
  • 04-22052121#1471~1485
  • 404Taichung CityTaichung NorthNo. 2, Yude Rd., North Dist., Taichung City 404332, Taiwan (R.O.C.)

Site Introduction

本中心前身為臨床研究中心,2008年起更名為「臨床試驗中心」(Clinical Trial Center, CTC),以推動本院臨床試驗為主要使命。
2010年起,由許重義教授擔任中心主持人至今。在許教授的帶領下,本中心連年獲得衛生福利部提升臨床試驗中心計畫支持。許教授管理理念為:以試驗委託者(Sponsor)及計畫主持人(PI)優先,提供國際級高品質與高效率的臨床試驗服務,以協助國內、外廠商執行臨床試驗,促成新藥或新醫材及早上市。目前本中心已是多國大藥廠(如諾華、輝瑞、賽諾菲等)以及試驗受託研究機構(Contract Research Organization, CRO)的優選合作機構。
本中心由五個不同功能、互相支援的團隊組成:
行政團隊(Administration):負責審閱及管理臨床試驗合約、檢體室管理、試驗案經費管理、計畫案經費控管與核銷、文件倉儲管理等。
研究護理師團隊(in-house SMO):提供研究護理師執行臨床試驗,並提供受試者最即時完善且專業的照顧。
試驗案管理團隊(Academic Research Organization, ARO):協助廠商或計畫主持人案件送審並監管試驗案品質。
教育訓練團隊(Training/Education):提供專業訓練課程、實體與線上學分課程,並舉辦國內外臨床試驗相關活動。
資料管理團隊(DryLab):提供臨床研究論文發表前所需之大數據資料庫統計分析服務。

Clinical Trials List

See All1850Cases

2016

Total 1850

  • I 108

  • I/II 69

  • II 403

  • II/III 56

  • III 1141

  • IV 24

  • Others 49

Number of Studies by Scale

121件

Taiwan Multiple Center

Taiwan Single Center

20Cases

Taiwan Multiple Center

121Cases

Multi-Regional Multi-Center

1673Cases

Principal Investigators - Rank by Total Number of Studies

No 1
PengCheng-Yuan

Total Studies93

  • Phase I

    2

  • Phase I/II

    3

  • Phase II

    37

  • Phase II/III

    1

  • Phase III

    40

  • Phase IV

    1

  • Others

    9

Phase I

2Cases

Phase I/II

3Cases

Phase II

37Cases

Phase II/III

1Cases

Phase III

40Cases

Phase IV

1Cases

Others

9Cases

No 2
HsiaTe-Chun

Total Studies169

  • Phase I

    7

  • Phase I/II

    6

  • Phase II

    39

  • Phase II/III

    6

  • Phase III

    106

  • Phase IV

    1

  • Others

    4

Phase I

7Cases

Phase I/II

6Cases

Phase II

39Cases

Phase II/III

6Cases

Phase III

106Cases

Phase IV

1Cases

Others

4Cases

No 3
WANGHWEI-CHUNG

Total Studies66

  • Phase I

    7

  • Phase II

    12

  • Phase II/III

    1

  • Phase III

    45

  • Others

    1

Phase I

7Cases

Phase I/II

0Cases

Phase II

12Cases

Phase II/III

1Cases

Phase III

45Cases

Phase IV

0Cases

Others

1Cases

No 4
BaiLi-Yuan

Total Studies167

  • Phase I

    32

  • Phase I/II

    17

  • Phase II

    45

  • Phase II/III

    11

  • Phase III

    57

  • Others

    5

Phase I

32Cases

Phase I/II

17Cases

Phase II

45Cases

Phase II/III

11Cases

Phase III

57Cases

Phase IV

0Cases

Others

5Cases

No 5
ChiuChang-Fang

Total Studies70

  • Phase I

    14

  • Phase I/II

    2

  • Phase II

    10

  • Phase II/III

    2

  • Phase III

    41

  • Others

    1

Phase I

14Cases

Phase I/II

2Cases

Phase II

10Cases

Phase II/III

2Cases

Phase III

41Cases

Phase IV

0Cases

Others

1Cases

No 6
ChangKuan-Cheng

Total Studies48

  • Phase II

    5

  • Phase II/III

    1

  • Phase III

    42

Phase I

0Cases

Phase I/II

0Cases

Phase II

5Cases

Phase II/III

1Cases

Phase III

42Cases

Phase IV

0Cases

Others

0Cases

No 7
HuangChung-Ming

Total Studies69

  • Phase II

    24

  • Phase II/III

    2

  • Phase III

    38

  • Phase IV

    3

  • Others

    2

Phase I

0Cases

Phase I/II

0Cases

Phase II

24Cases

Phase II/III

2Cases

Phase III

38Cases

Phase IV

3Cases

Others

2Cases

No 8
YehSu-Peng

Total Studies219

  • Phase I

    26

  • Phase I/II

    17

  • Phase II

    36

  • Phase II/III

    6

  • Phase III

    125

  • Phase IV

    7

  • Others

    2

Phase I

26Cases

Phase I/II

17Cases

Phase II

36Cases

Phase II/III

6Cases

Phase III

125Cases

Phase IV

7Cases

Others

2Cases

No 9
LanJoung-Liang

Total Studies84

  • Phase I

    1

  • Phase II

    29

  • Phase II/III

    2

  • Phase III

    51

  • Phase IV

    1

Phase I

1Cases

Phase I/II

0Cases

Phase II

29Cases

Phase II/III

2Cases

Phase III

51Cases

Phase IV

1Cases

Others

0Cases

No 10
ChouJen-Wei

Total Studies57

  • Phase II

    23

  • Phase II/III

    2

  • Phase III

    32

Phase I

0Cases

Phase I/II

0Cases

Phase II

23Cases

Phase II/III

2Cases

Phase III

32Cases

Phase IV

0Cases

Others

0Cases

Patient Recruitment Ranking